$28.94
+1.72 (+6.32%)
Performance
1D
—
1W
—
1M
—
3M
+5.27%
6M
+26.43%
1Y
+98.90%
YTD
+11.69%
Open$27.32
Previous Close$27.22
Day High$29.85
Day Low$27.16
52W High$30.09
52W Low$13.36
Volume—
Avg Volume1.40M
Market Cap5.54B
P/E Ratio—
EPS$-2.68
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.99
Above
SMA 200
$19.59
Above
RSI (14)
49.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+110.6% upside
Current
$28.94
$28.94
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.40B | 1.44B | 1.30B |
| Net Income | 261.90M | 339.04M | 251.92M |
| Profit Margin | 18.7% | 23.6% | 19.4% |
| EBITDA | 403.28M | 390.65M | 352.93M |
| Free Cash Flow | 259.22M | 284.01M | 237.35M |
| Rev Growth | +1.7% | -7.0% | +15.8% |
| Debt/Equity | 0.75 | 0.69 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |